✦ LIBER ✦

376 - Employment of the mdr1 promoter for a conditionally active retroviral vector system in cancer gene therapy

✍ Scribed by W. Walther; U. Stein; J. Wendt; R.H. Shoemaker

Book ID: 117664631
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 264 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)84800-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Employment of the mdr1 promoter for the

Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy

✍ Walther, W; Wendt, J; Stein, U 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 516 KB

A Novel Adenoviral Vector Regulated by t

A Novel Adenoviral Vector Regulated by the Caveolin-1 Promoter for in Situ Prostate Cancer Gene Therapy

✍ Pramudji, C.K.; Shimura, S.; Ebara, S.; Yang, G.; Ren, C.; Thompson, T.C. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Development of an in vitro cell culture

Development of an in vitro cell culture assay system for measuring the activation of a neighbouring gene by the retroviral vector

✍ Youngtae Hong; Seung Shin Yu; Nam-Kyung Yoon; Sung June Kang; Jun-Tae Lee; Sujeo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract ## Background The use of retroviral vectors has shown an actual clinical benefit in a few inherited diseases. However, the occurrence of cases of leukemia after the X‐SCID gene therapy trial raised concerns about the safety of insertional mutagenesis inherent to the biology of the retr

A proposal for the physiological signifi

A proposal for the physiological significance of mdr1 and Bcrp1/Abcg2 gene expression in normal tissue regeneration and after cancer therapy

✍ David Israeli; Simin Ziaei; Patrick Gonin; Luis Garcia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Cellular multi-drug resistance (MDR), which often develops in cancer cells of patients subjected to anti-cancer treatment, remains a significant barrier to successful cancer therapy. One of the principal causes of cellular MDR development is an increased expression of ABC-transporter genes such as m